![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Akbas M, Mumtaz Koyuncu F, Oludag Mete T, Taneli F, Ozdemir H, Yilmaz O. 2019. Serum levels of spexin are increased in the third trimester pregnancy with gestational diabetes mellitus. Gynecological Endocrinology 35:1050–1053.
- Al Kindi MK, Al Essry FS, Al Essry FS, Mula-Abed W-A. 2012. Validity of serum testosterone, free androgen index, and calculated free testosterone in women with suspected hyperandrogenism. Oman Medical Journal 27:471–474.
- Anon. 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 19:41–47.
- Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. 2004. The prevalence and features of the polycystic ovary syndrome in an unselected population. The Journal of Clinical Endocrinology & Metabolism 89:2745–2749.
- Dunaif A. 1997. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews 18:774–800.
- Ehrmann DA. 2005. Polycystic ovary syndrome. New England Journal of Medicine 352:1223–1236.
- Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN. 2006. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism 91:48–53.
- Ferriman D, Gallwey JD. 1961. Clinical assessment of body hair growth in women. The Journal of Clinical Endocrinology & Metabolism 21:1440–1447.
- Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 18:499–502.
- Geloneze B, Repetto EM, Geloneze SR, Tambascia MA, Ermetice MN. 2006. The threshold value for insulin resistance (HOMA-IR) in an admixtured population IR in the Brazilian Metabolic Syndrome Study. Diabetes Research and Clinical Practice 72:219–220.
- Gu L, Ma Y, Gu M, Zhang Y, Yan S, Li N, et al. 2015. Spexin peptide is expressed in human endocrine and epithelial tissues and reduced after glucose load in type 2 diabetes. Peptides 71:232–239.
- Liu Y, Li S, Qi X, Zhou W, Liu X, Lin H, et al. 2013. A novel neuropeptide in suppressing luteinizing hormone release in goldfish, Carassius auratus. Molecular and Cellular Endocrinology 374:65–72.
- March WA, Moore VM, Willson KJ, Phillips DIW, Norman RJ, Davies MJ. 2010. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Human Reproduction 25:544–551.
- Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419.
- Sassek M, Kolodziejski PA, Szczepankiewicz D, Pruszynska-Oszmalek E. 2019. Spexin in the physiology of pancreatic islets—mutual interactions with insulin. Endocrine 63:513–519.
- Trudeau VL. 2018. Facing the challenges of neuropeptide gene knockouts: why do they not inhibit reproduction in adult teleost fish?. Frontiers in Neuroscience 12:302.
- Walewski JL, Ge F, Lobdell H, Levin N, Schwartz GJ, Vasselli JR, et al. 2014. Spexin is a novel human peptide that reduces adipocyte uptake of long chain fatty acids and causes weight loss in rodents with diet-induced obesity. Obesity 22:1643–1652.